Literature DB >> 19723455

Assessment of myocardial ischemia and viability using cardiac magnetic resonance.

Nuno Bettencourt1, Amedeo Chiribiri, Andreas Schuster, Eike Nagel.   

Abstract

In the past decade, cardiac magnetic resonance (CMR) has evolved dramatically. Its clinical applications are now a major tool in the diagnosis and prognostic assessment of patients with ischemic heart disease. CMR can be used for detection and quantification of ischemia and for viability assessment using different techniques that are now well validated. Scar can be easily detected using contrast enhancement (late gadolinium enhancement). Ischemia detection is usually achieved with stress CMR techniques, whereas prediction for the recovery of function (detection of dysfunctional but viable myocardial segments) can be deduced from scar and stress imaging. Although determination of which approach is better may depend on the population group, the major advantage of CMR is the ability to integrate different information about anatomy, wall motion, myocardial perfusion, and tissue characterization in a single comprehensive examination.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19723455     DOI: 10.1007/s11897-009-0021-9

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  83 in total

1.  Acute myocardial infarction: myocardial viability assessment in patients early thereafter comparison of contrast-enhanced MR imaging with resting (201)Tl SPECT. Single photon emission computed tomography.

Authors:  Kakuya Kitagawa; Hajime Sakuma; Tadanori Hirano; Shinya Okamoto; Katsutoshi Makino; Kan Takeda
Journal:  Radiology       Date:  2003-01       Impact factor: 11.105

2.  Quantitative magnetic resonance perfusion imaging detects anatomic and physiologic coronary artery disease as measured by coronary angiography and fractional flow reserve.

Authors:  Marco A Costa; Steven Shoemaker; Hideki Futamatsu; Chris Klassen; Dominick J Angiolillo; Minh Nguyen; Alan Siuciak; Paul Gilmore; Martin M Zenni; Luis Guzman; Theodore A Bass; Norbert Wilke
Journal:  J Am Coll Cardiol       Date:  2007-07-23       Impact factor: 24.094

3.  Cardiac magnetic resonance perfusion imaging for the functional assessment of coronary artery disease: a comparison with coronary angiography and fractional flow reserve.

Authors:  Johannes Rieber; Armin Huber; Isabelle Erhard; Silvia Mueller; Michael Schweyer; Andreas Koenig; Thomas M Schiele; Karl Theisen; Uwe Siebert; Stefan O Schoenberg; Maximilian Reiser; Volker Klauss
Journal:  Eur Heart J       Date:  2006-05-23       Impact factor: 29.983

4.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

Authors:  R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

5.  Effect of the transmural extent of myocardial scar on left ventricular systolic wall thickening during intravenous dobutamine administration.

Authors:  Pairoj Rerkpattanapipat; William C Little; Hollins P Clark; Craig A Hamilton; Kerry M Link; W Gregory Hundley
Journal:  Am J Cardiol       Date:  2005-02-15       Impact factor: 2.778

6.  Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography.

Authors:  E Nagel; H B Lehmkuhl; W Bocksch; C Klein; U Vogel; E Frantz; A Ellmer; S Dreysse; E Fleck
Journal:  Circulation       Date:  1999-02-16       Impact factor: 29.690

7.  Myocardial first-pass perfusion magnetic resonance imaging: a multicenter dose-ranging study.

Authors:  S D Wolff; J Schwitter; R Coulden; M G Friedrich; D A Bluemke; R W Biederman; E T Martin; A J Lansky; F Kashanian; T K F Foo; P E Licato; C R Comeau
Journal:  Circulation       Date:  2004-08-02       Impact factor: 29.690

Review 8.  Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis.

Authors:  Kiran R Nandalur; Ben A Dwamena; Asim F Choudhri; Mohan R Nandalur; Ruth C Carlos
Journal:  J Am Coll Cardiol       Date:  2007-09-17       Impact factor: 24.094

9.  Risk stratification by adenosine stress cardiac magnetic resonance in patients with coronary artery stenoses of intermediate angiographic severity.

Authors:  Christina Doesch; Achim Seeger; Jörg Doering; Christian Herdeg; Christof Burgstahler; Claus D Claussen; Meinrad Gawaz; Stephan Miller; Andreas E May
Journal:  JACC Cardiovasc Imaging       Date:  2009-04

10.  Quantification of late gadolinium enhanced CMR in viability assessment in chronic ischemic heart disease: a comparison to functional outcome.

Authors:  Aernout M Beek; Olga Bondarenko; Farshid Afsharzada; Albert C van Rossum
Journal:  J Cardiovasc Magn Reson       Date:  2009-03-09       Impact factor: 5.364

View more
  10 in total

1.  Quantitative assessment of magnetic resonance derived myocardial perfusion measurements using advanced techniques: microsphere validation in an explanted pig heart system.

Authors:  Andreas Schuster; Niloufar Zarinabad; Masaki Ishida; Matthew Sinclair; Jeroen Phm van den Wijngaard; Geraint Morton; Gilion Ltf Hautvast; Boris Bigalke; Pepijn van Horssen; Nicolas Smith; Jos Ae Spaan; Maria Siebes; Amedeo Chiribiri; Eike Nagel
Journal:  J Cardiovasc Magn Reson       Date:  2014-10-14       Impact factor: 5.364

Review 2.  Myocardial Viability on Cardiac Magnetic Resonance.

Authors:  Ana Luiza Mansur Souto; Rafael Mansur Souto; Isabella Cristina Resende Teixeira; Marcelo Souto Nacif
Journal:  Arq Bras Cardiol       Date:  2017-05       Impact factor: 2.000

3.  An isolated perfused pig heart model for the development, validation and translation of novel cardiovascular magnetic resonance techniques.

Authors:  Andreas Schuster; Inga Grünwald; Amedeo Chiribiri; Richard Southworth; Masaki Ishida; Gunnar Hay; Nicole Neumann; Geraint Morton; Divaka Perera; Tobias Schaeffter; Eike Nagel
Journal:  J Cardiovasc Magn Reson       Date:  2010-09-17       Impact factor: 5.364

4.  Myocardial feature tracking reduces observer-dependence in low-dose dobutamine stress cardiovascular magnetic resonance.

Authors:  Andreas Schuster; Matthias Paul; Nuno Bettencourt; Shazia T Hussain; Geraint Morton; Shelby Kutty; Boris Bigalke; Amedeo Chiribiri; Divaka Perera; Eike Nagel; Philipp Beerbaum
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

Review 5.  Role of cardiovascular magnetic resonance in acute and chronic ischemic heart disease.

Authors:  A Baritussio; A Scatteia; C Bucciarelli-Ducci
Journal:  Int J Cardiovasc Imaging       Date:  2017-03-18       Impact factor: 2.357

Review 6.  CMR for myocardial characterization in ischemic heart disease: state-of-the-art and future developments.

Authors:  Tilman Emrich; Moritz Halfmann; U Joseph Schoepf; Karl-Friedrich Kreitner
Journal:  Eur Radiol Exp       Date:  2021-03-25

Review 7.  Quantification of Myocardial Deformation Applying CMR-Feature-Tracking-All About the Left Ventricle?

Authors:  Torben Lange; Andreas Schuster
Journal:  Curr Heart Fail Rep       Date:  2021-05-01

8.  Low-dose dobutamine cardiovascular magnetic resonance segmental strain study of early phase of intramyocardial hemorrhage rats.

Authors:  Rui Xia; Bo He; Tong Zhu; Yu Zhang; Yushu Chen; Lei Wang; Yang Zhou; Jichun Liao; Jie Zheng; Yongmei Li; Fajin Lv; Fabao Gao
Journal:  BMC Med Imaging       Date:  2021-11-20       Impact factor: 1.930

9.  Cardiovascular magnetic resonance imaging of isolated perfused pig hearts in a 3T clinical MR scanner.

Authors:  Andreas Schuster; Amedeo Chiribiri; Masaki Ishida; Geraint Morton; Matthias Paul; Shazia T Hussain; Boris Bigalke; Divaka Perera; Tobias Schaeffter; Eike Nagel
Journal:  Interv Med Appl Sci       Date:  2012-12-27

Review 10.  Review of Journal of Cardiovascular Magnetic Resonance 2011.

Authors:  Dudley J Pennell; John Paul Carpenter; David N Firmin; Philip J Kilner; Raad H Mohiaddin; Sanjay K Prasad
Journal:  J Cardiovasc Magn Reson       Date:  2012-11-18       Impact factor: 5.364

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.